Establishment Labs Holdings Inc (ESTA)
37.51
-1.81
(-4.60%)
USD |
NASDAQ |
Nov 14, 16:00
37.51
0.00 (0.00%)
After-Hours: 20:00
Establishment Labs Holdings Revenue (Quarterly): 40.23M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.23M |
| June 30, 2024 | 44.12M |
| March 31, 2024 | 37.17M |
| December 31, 2023 | 31.56M |
| September 30, 2023 | 38.51M |
| June 30, 2023 | 48.56M |
| March 31, 2023 | 46.52M |
| December 31, 2022 | 43.81M |
| September 30, 2022 | 38.24M |
| June 30, 2022 | 41.19M |
| March 31, 2022 | 38.45M |
| December 31, 2021 | 35.31M |
| September 30, 2021 | 29.04M |
| June 30, 2021 | 31.99M |
| March 31, 2021 | 30.34M |
| December 31, 2020 | 26.96M |
| Date | Value |
|---|---|
| September 30, 2020 | 22.76M |
| June 30, 2020 | 10.47M |
| March 31, 2020 | 24.48M |
| December 31, 2019 | 24.25M |
| September 30, 2019 | 22.85M |
| June 30, 2019 | 21.68M |
| March 31, 2019 | 20.78M |
| December 31, 2018 | 16.40M |
| September 30, 2018 | 16.29M |
| June 30, 2018 | 13.71M |
| March 31, 2018 | 14.82M |
| December 31, 2017 | 11.81M |
| September 30, 2017 | 7.324M |
| June 30, 2017 | 8.627M |
| March 31, 2017 | 6.919M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.47M
Minimum
Jun 2020
48.56M
Maximum
Jun 2023
34.20M
Average
36.24M
Median
Revenue (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 11.89B |
| Cassava Sciences Inc | -- |
| Aytu BioPharma Inc | 17.98M |
| enVVeno Medical Corp | -- |
| Onconetix Inc | 0.7048M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.68M |
| Total Expenses (Quarterly) | 53.37M |
| EPS Diluted (Quarterly) | -0.59 |
| Enterprise Value | 1.286B |
| Gross Profit Margin (Quarterly) | 63.93% |
| Profit Margin (Quarterly) | -41.47% |
| Earnings Yield | -6.88% |
| Normalized Earnings Yield | -6.878 |